Regarding the publication �Rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation and stage IV-V chronic kidney disease�

Shoar, S. and Shoar, N. and Naderan, M. and Modukuru, V.R. (2020) Regarding the publication �Rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation and stage IV-V chronic kidney disease�. American Heart Journal, 223. p. 110.

Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....
DOI: UNSPECIFIED
Item Type: Article
Additional Information: cited By 0
Uncontrolled Keywords: rivaroxaban; warfarin, anticoagulant therapy; atrial fibrillation; bleeding; chronic kidney failure; follow up; gastrointestinal hemorrhage; hospitalization; human; kidney function; Letter; practice guideline; priority journal; renal replacement therapy
Subjects: Medicine
Pharmacology, Toxicology and Pharmaceutics
Divisions: Faculty of Medicine > Clinical Sciences > Department of Cardiology
Depositing User: ART . editor
Date Deposited: 27 Jun 2020 12:29
Last Modified: 27 Jun 2020 12:29
URI: http://eprints.kaums.ac.ir/id/eprint/4923

Actions (login required)

View Item View Item